New: medicn

currentaffairs (26)in news • 7 years ago
Big Pharma Doesn't Want Health Outcomes To Sway Pricing
When Novartis announced that the price of its new personalized gene therapy for cancer, Kymriah, would be $475,000, Wall Street analysts thought that was a relative bargain, but some health payers…
Downvoting a post can decrease pending rewards and make it less visible. Common reasons:
Disagreement on rewards
Fraud or plagiarism
Hate speech or trolling
Miscategorized content or spam

Submit
$0.00
1

Big Pharma Doesn't Want Health Outcomes To Sway Pricing